Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Diaphragm movement and breathing drive in people with OSA, COPD, or both

Official title: Diaphragmatic Morphofunction and Respiratory Drive in OSA and COPD: Insights From Ultrasound and EMG-based Cross-Sectional Analysis

Run by Nanjing Medical University · NCT07003399 · Data updated 2026-11-12

Using ultrasound and surface diaphragm EMG, this cross-sectional study will see if diaphragm movement and breathing drive differ between people with OSA, COPD, both conditions, and healthy adults.

More Obstructive Sleep Apnea trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment80 (estimated)
SponsorNanjing Medical University
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedAugust 31, 2025
Study endsAugust 31, 2025
Registry record updatedJune 25, 2025
Trial IDNCT07003399 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 who can give informed consent and who have OSA (AHI ≥ 5), COPD per GOLD criteria, both conditions (overlap), or are healthy volunteers without respiratory or sleep disorders are ideal candidates.

Probably not a fit

People with severe cardiovascular, hepatic, or renal disease, neuromuscular disorders affecting respiratory muscles, recent upper airway or thoracic surgery, pregnant or breastfeeding women, or those unable to complete testing are excluded and unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, cross-sectional study compares diaphragmatic structure and respiratory drive across four groups: OSA, COPD, overlap syndrome, and healthy controls. Participants will undergo overnight polysomnography, spirometry, impulse oscillometry, diaphragm ultrasound, and surface diaphragm EMG to measure thickness, excursion, thickening fraction, and EMGdi parameters (rest, max, %max). Investigators will compare group differences and examine relationships between diaphragmatic indicators and respiratory measures such as FEV1, FVC, AHI, and R5-R20. The aim is to identify objective diaphragmatic markers that could characterize dysfunction and help differentiate overlap syndrome.

Why it matters

Potential benefit: If successful, the findings could provide objective diaphragmatic markers to help distinguish overlap syndrome from OSA or COPD and support more targeted clinical assessment.

How similar studies have gone: Previous work using diaphragm ultrasound and EMG in COPD and some OSA cohorts has shown promising but limited results, while targeted assessment of overlap syndrome remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients aged between 18 and 80 years.
2. For OSA Group: Diagnosed obstructive sleep apnea with AHI ≥ 5 events/hour based on overnight polysomnography.
3. For COPD Group: Diagnosed chronic obstructive pulmonary disease based on GOLD guidelines.
4. For Overlap Group: Diagnosed both OSA (AHI ≥ 5) and COPD.
5. For Control Group: Healthy volunteers with no known respiratory diseases or sleep disorders.
6. Ability and willingness to provide informed consent for participation in the study.

Exclusion Criteria:

1. Severe cardiovascular diseases (e.g., unstable angina, heart failure NYHA III/IV).
2. Severe hepatic or renal insufficiency.
3. Neuromuscular diseases affecting respiratory muscles.
4. Recent upper airway or thoracic surgery (within 3 months).
5. Pregnancy or breastfeeding.
6. Participants who cannot complete assessments due to cognitive impairment or poor cooperation.

Where it's running

  • The First Affiliated Hospital of Nanjing Medical University
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.